Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hypertension

  Free Subscription


Articles published in J Am Coll Cardiol

Retrieve available abstracts of 51 articles:
HTML format
Text format



Single Articles


    December 2018
  1. DIMOPOULOS K, Condliffe R, Tulloh RMR, Clift P, et al
    Echocardiographic Screening for Pulmonary Hypertension in Congenital Heart Disease: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2018;72:2778-2788.
    PubMed     Text format     Abstract available


    October 2018
  2. LIU B, Sun Y, Xu G, Rong S, et al
    Long-Term Trends in Hypertension and Elevated Blood Pressure Among U.S. Adults, 1999 to 2016.
    J Am Coll Cardiol. 2018;72:2089-2091.
    PubMed     Text format    


    September 2018
  3. MELENDEZ GC, Jordan JH, D'Agostino RB Jr, Lesnefsky EJ, et al
    Accelerated Left Ventricular Interstitial Collagen Deposition After Receiving Doxorubicin in Hypertension.
    J Am Coll Cardiol. 2018;72:1555-1557.
    PubMed     Text format    


  4. TURAGAM MK, Vuddanda V, Verberkmoes N, Ohtsuka T, et al
    Epicardial Left Atrial Appendage Exclusion Reduces Blood Pressure in Patients With Atrial Fibrillation and Hypertension.
    J Am Coll Cardiol. 2018;72:1346-1353.
    PubMed     Text format     Abstract available


  5. MAGNUS MC, Hughes AD, Williams C, Chaturvedi N, et al
    Hypertensive Disorders During Pregnancy and Offspring Retinal Microvasculature During Adolescence.
    J Am Coll Cardiol. 2018;72:1318-1320.
    PubMed     Text format    


  6. CAREY RM, Muntner P, Bosworth HB, Whelton PK, et al
    Prevention and Control of Hypertension: JACC Health Promotion Series.
    J Am Coll Cardiol. 2018;72:1278-1293.
    PubMed     Text format     Abstract available


  7. MEISTER TA, Rimoldi SF, Soria R, von Arx R, et al
    Association of Assisted Reproductive Technologies With Arterial Hypertension During Adolescence.
    J Am Coll Cardiol. 2018;72:1267-1274.
    PubMed     Text format     Abstract available


  8. CATOV JM, Countouris M, Hauspurg A
    Hypertensive Disorders of Pregnancy and CVD Prediction: Accounting for Risk Accrual During the Reproductive Years.
    J Am Coll Cardiol. 2018;72:1264-1266.
    PubMed     Text format    


  9. STUART JJ, Tanz LJ, Cook NR, Spiegelman D, et al
    Hypertensive Disorders of Pregnancy and 10-Year Cardiovascular Risk Prediction.
    J Am Coll Cardiol. 2018;72:1252-1263.
    PubMed     Text format     Abstract available


  10. PHILLIPS RA, Arnold RM, Peterson LE
    Hypertension Guidelines: The Threads That Bind Them.
    J Am Coll Cardiol. 2018;72:1246-1251.
    PubMed     Text format    


  11. TALER SJ
    Epidemiological Versus Trial Evidence for Hypertension Treatment: Adding a Piece to the Puzzle.
    J Am Coll Cardiol. 2018;72:1211-1213.
    PubMed     Text format    


  12. QI Y, Han X, Zhao D, Wang W, et al
    Long-Term Cardiovascular Risk Associated With Stage 1 Hypertension Defined by the 2017 ACC/AHA Hypertension Guideline.
    J Am Coll Cardiol. 2018;72:1201-1210.
    PubMed     Text format     Abstract available


    August 2018
  13. BIGOTTE VIEIRA M, Magrico R, Viegas Dias C, Leitao L, et al
    Renal Outcomes and the Relative Benefit and Harm of Intensive Treatment of Hypertension.
    J Am Coll Cardiol. 2018;72:817-818.
    PubMed     Text format    


    June 2018
  14. HOSHIDE S, Yano Y, Kanegae H, Kario K, et al
    Effect of Lowering Home Blood Pressure on Subclinical Cardiovascular Disease in Masked Uncontrolled Hypertension.
    J Am Coll Cardiol. 2018;71:2858-2859.
    PubMed     Text format    


    May 2018
  15. MAHMUD E, Madani MM, Kim NH, Poch D, et al
    Chronic Thromboembolic Pulmonary Hypertension: Evolving Therapeutic Approaches for Operable and Inoperable Disease.
    J Am Coll Cardiol. 2018;71:2468-2486.
    PubMed     Text format     Abstract available


    April 2018
  16. WENGER NK, Arnold A, Bairey Merz CN, Cooper-DeHoff RM, et al
    Hypertension Across a Woman's Life Cycle.
    J Am Coll Cardiol. 2018;71:1797-1813.
    PubMed     Text format     Abstract available


  17. JURASCHEK SP, Miller ER 3rd, Appel LJ
    Reply: The Role of Salt Reduction in the Management of Hypertension.
    J Am Coll Cardiol. 2018;71:1598-1599.
    PubMed     Text format    


  18. BLUMENTHAL JA, Sherwood A, Smith PJ, Hinderliter A, et al
    The Role of Salt Reduction in the Management of Hypertension.
    J Am Coll Cardiol. 2018;71:1597-1598.
    PubMed     Text format    


  19. MESSERLI FH, Bangalore S, Bavishi C, Rimoldi SF, et al
    Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use?
    J Am Coll Cardiol. 2018;71:1474-1482.
    PubMed     Text format     Abstract available


    March 2018
  20. WHITE WB
    Clinical Precision in the Management of Hypertension: Improving Upon the "One-Size-Fits-All" Approach.
    J Am Coll Cardiol. 2018 Mar 2. pii: S0735-1097(18)33228.
    PubMed     Text format    


  21. PHILLIPS RA, Xu J, Peterson LE, Arnold RM, et al
    Impact of Cardiovascular Risk on the Relative Benefit and Harm of Intensive Treatment of Hypertension.
    J Am Coll Cardiol. 2018 Mar 2. pii: S0735-1097(18)33226.
    PubMed     Text format     Abstract available


    February 2018
  22. JIMENEZ D, Quezada CA, Escribano P
    Surrogate Endpoints for Pulmonary Hypertension Management and Trial Design: Moving in the Right Direction.
    J Am Coll Cardiol. 2018;71:764-765.
    PubMed     Text format    


  23. MCLAUGHLIN VV, Hoeper MM, Channick RN, Chin KM, et al
    Pulmonary Arterial Hypertension-Related Morbidity Is Prognostic for Mortality.
    J Am Coll Cardiol. 2018;71:752-763.
    PubMed     Text format     Abstract available


    December 2017
  24. JURASCHEK SP, Miller ER 3rd, Weaver CM, Appel LJ, et al
    Effects of Sodium Reduction and the DASH Diet in Relation to Baseline Blood Pressure.
    J Am Coll Cardiol. 2017;70:2841-2848.
    PubMed     Text format     Abstract available


    November 2017
  25. SAIA F, Palazzini M, Taglieri N, Manes A, et al
    Reply: Left Main Extrinsic Compression in Pulmonary Arterial Hypertension: From Identification to Percutaneous Coronary Intervention Optimization.
    J Am Coll Cardiol. 2017;70:2460-2461.
    PubMed     Text format    


  26. MONTERO CABEZAS JM, Nuche Berenguer J, Velazquez Martin MT, Escribano Subias P, et al
    Left Main Extrinsic Compression in Pulmonary Arterial Hypertension: From Identification to Percutaneous Coronary Intervention Optimization.
    J Am Coll Cardiol. 2017;70:2459-2460.
    PubMed     Text format    


  27. REDDY YNV, Borlaug BA
    Reply: Heart Failure With Preserved Ejection Fraction: A Late Stage of Hypertensive Heart Disease.
    J Am Coll Cardiol. 2017;70:2458-2459.
    PubMed     Text format    


  28. MESSERLI FH, Rimoldi SF, Wilhelm M
    Heart Failure With Preserved Ejection Fraction: A Late Stage of Hypertensive Heart Disease.
    J Am Coll Cardiol. 2017;70:2458.
    PubMed     Text format    


    October 2017
  29. HONG KN, Fuster V, Rosenson RS, Rosendorff C, et al
    How Low to Go With Glucose, Cholesterol, and Blood Pressure in Primary Prevention of CVD.
    J Am Coll Cardiol. 2017;70:2171-2185.
    PubMed     Text format     Abstract available


    August 2017
  30. SELVARAJ S, Djousse L, Aguilar FG, Martinez EE, et al
    Association of Estimated Sodium Intake With Adverse Cardiac Structure and Function: From the HyperGEN Study.
    J Am Coll Cardiol. 2017;70:715-724.
    PubMed     Text format     Abstract available


    July 2017
  31. BAVISHI C, Bangalore S, Messerli FH
    Reply: Hypertension Treatment in the Elderly: Individualized Target or Intensive Blood Pressure Lowering?
    J Am Coll Cardiol. 2017;70:510.
    PubMed     Text format    


  32. ABDELKARIM I, Althouse AD, Thoma FW, Lee JS, et al
    The Importance of Invasive Hemodynamics for Pulmonary Hypertension Screening in TAVR Patients.
    J Am Coll Cardiol. 2017;70:510-511.
    PubMed     Text format    


  33. HUANG Y, Li M, Huang W
    Hypertension Treatment in the Elderly: Individualized Target or Intensive Blood Pressure Lowering?
    J Am Coll Cardiol. 2017;70:509-510.
    PubMed     Text format    


  34. BAVISHI C, Bangalore S, Messerli FH
    Reply: Adequate Blood Pressure Control and Monitoring Acute Kidney Injury in Older Hypertensive Patients.
    J Am Coll Cardiol. 2017;70:120.
    PubMed     Text format    


  35. NARANJO M, Mezue K, Rangaswami J
    Outcomes of Intensive Blood Pressure Lowering in Older Hypertensive Patients: Should AKI Be Watched?
    J Am Coll Cardiol. 2017;70:119-120.
    PubMed     Text format    


    June 2017
  36. HUANG Y, Huang W, Hu Y
    Is White-Coat Hypertension Associated With Risk of Cardiovascular Diseases?
    J Am Coll Cardiol. 2017;69:2880.
    PubMed     Text format    


  37. FRANKLIN SS, Thijs L, Staessen JA
    Reply: Is White-Coat Hypertension Associated With Risk of Cardiovascular Diseases?
    J Am Coll Cardiol. 2017;69:2880-2881.
    PubMed     Text format    


  38. ALFONSO F, Rivero F
    Left Main Coronary Artery Compression in Patients With Pulmonary Arterial Hypertension.
    J Am Coll Cardiol. 2017;69:2818-2820.
    PubMed     Text format    


  39. GALIE N, Saia F, Palazzini M, Manes A, et al
    Left Main Coronary Artery Compression in Patients With Pulmonary Arterial Hypertension and Angina.
    J Am Coll Cardiol. 2017;69:2808-2817.
    PubMed     Text format     Abstract available


    May 2017
  40. HANSMANN G
    Pulmonary Hypertension in Infants, Children, and Young Adults.
    J Am Coll Cardiol. 2017;69:2551-2569.
    PubMed     Text format     Abstract available


  41. MUNTNER P, Whelton PK
    Using Predicted Cardiovascular Disease Risk in Conjunction With Blood Pressure to Guide Antihypertensive Medication Treatment.
    J Am Coll Cardiol. 2017;69:2446-2456.
    PubMed     Text format     Abstract available


    April 2017
  42. MAIOLINO G, Calo LA, Rossi GP
    The Time has Come for Systematic Screening for Primary Aldosteronism in All Hypertensives.
    J Am Coll Cardiol. 2017;69:1821-1823.
    PubMed     Text format    


  43. GUAZZI M, Naeije R
    Pulmonary Hypertension in Heart Failure: Pathophysiology, Pathobiology, and Emerging Clinical Perspectives.
    J Am Coll Cardiol. 2017;69:1718-1734.
    PubMed     Text format     Abstract available


    March 2017
  44. MARCUS Y, Osher E, Stern N
    In the Treatment of Hypertension, Lowering of Diastolic Pressure to <70 mm Hg Is Often Unavoidable.
    J Am Coll Cardiol. 2017;69:1647-1648.
    PubMed     Text format    


  45. NADKARNI GN, Galarneau G, Ellis SB, Nadukuru R, et al
    Apolipoprotein L1 Variants and Blood Pressure Traits in African Americans.
    J Am Coll Cardiol. 2017;69:1564-1574.
    PubMed     Text format     Abstract available


    February 2017
  46. SINGH RR, Sajeesh V, Booth LC, McArdle Z, et al
    Catheter-Based Renal Denervation Exacerbates Blood Pressure Fall During Hemorrhage.
    J Am Coll Cardiol. 2017;69:951-964.
    PubMed     Text format     Abstract available


    September 2016
  47. GOSMANOVA EO, Mikkelsen MK, Molnar MZ, Lu JL, et al
    Association of Systolic Blood Pressure Variability With Mortality, Coronary Heart Disease, Stroke, and Renal Disease.
    J Am Coll Cardiol. 2016;68:1375-86.
    PubMed     Text format     Abstract available


    July 2016
  48. SELVARAJ S, Steg PG, Elbez Y, Sorbets E, et al
    Reply: Pulse Pressure and Cardiovascular Death.
    J Am Coll Cardiol. 2016;68:132-3.
    PubMed     Text format    


  49. AZNAOURIDIS K, Vlachopoulos C, Tousoulis D
    Pulse Pressure and Cardiovascular Death.
    J Am Coll Cardiol. 2016;68:131-2.
    PubMed     Text format    


    April 2016
  50. KARIO K, Saito I, Kushiro T, Teramukai S, et al
    Morning Home Blood Pressure Is a Strong Predictor of Coronary Artery Disease: The HONEST Study.
    J Am Coll Cardiol. 2016;67:1519-27.
    PubMed     Text format     Abstract available


  51. KNOWLES JW, Reaven G
    Usual Blood Pressure and New-Onset Diabetes Risk: Evidence From 4.1 Million Adults and a Meta-Analysis.
    J Am Coll Cardiol. 2016;67:1656-7.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: